Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.1 USD | +1.84% | -3.02% | +24.74% |
May. 17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.74% | 189M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Earnings Flash (CAPR) CAPRICOR THERAPEUTICS Posts Q2 Revenue $3.9M, vs. Street Est of $1.6M